Aveanna Healthcare Holdings Inc AVAH 深 沪
已收盘 05-22 16:00:00 美东时间
7.33
-0.340
-4.43%
华盛通- 最 高7.6699
- 今 开7.64
- 成交量 143.39万股
- 最 低 7.30
- 昨 收 7.67
- 总市值 15.96亿
- 52周最高 10.32
- 市盈率 静 7.00
- 换手率 0.66%
- 52周最低 3.73
- 委 比 -0.96%
- 总股本 2.18亿
- 历史最高 13.00
- 量 比 0.71
- 振 幅 4.82%
- 历史最低 0.6664
- 每 手 1
- 风险率 1.67%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | Cava、CrowdStrike、Keysight获多家大行上调目标价；家得宝绩后遭多家大行下调目标价
今日重点评级关注：Oppenheimer：维持Protara Therapeutics"跑赢大市"评级，目标价从25美元升至28美元；Piper Sandler：维持Bright Minds Biosciences"超配"评级，目标价从190美元升至220美元
05-21 12:05
美股大行评级 | 花旗上调英特尔目标价至130美元；大摩上调英伟达目标价至285美元；National 、Yesway获多家大行首予买入评级
今日重点评级关注：TD Cowen：维持Strive"买入"评级，目标价从28美元升至30美元；蒙特利尔银行：维持KinderCare Learning"跑赢大市"评级，目标价从4美元升至6美元
05-19 10:55
U.S. RESEARCH ROUNDUP-Exxon Mobil, Northrop Grumman, Regeneron Pharmaceuticals
U.S. RESEARCH ROUNDUP-Exxon Mobil, Northrop Grumman, Regeneron Pharmaceuticals May 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Exxon Mobil, Northrop Grumman and Regeneron Pharmaceuticals on Monday. HIGHLIGHTS * Ch
05-18 15:15
美股大行评级 | 应用材料获17家大行集体上调目标价；Bitdeer 、Forgent 、嘉信理财、Viking等获多家大行上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从11美元升至12美元；Ladenburg Thalmann：维持Usio"买入"评级，目标价从5.75美元升至6.25美元
05-18 11:48
Aveanna Healthcare Hldgs Reports Q1 2026 Results: Full Earnings Call Transcript
On Thursday, Aveanna Healthcare Hldgs (NASDAQ:AVAH) discussed first-quarter fin...
05-14 23:28
Aveanna Healthcare beats Q1 estimates, raises FY guidance
Aveanna Healthcare Holdings press release (AVAH): Q1 Non-GAAP EPS of $0.18 beats by $0.05. Revenue of $647.9M (+15.9% Y/Y) beats by $34.66M. Increased Full Year 2026 Revenue guidance to between $2.56 ...
05-14 19:12
Earnings Scheduled For May 14, 2026
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
Aveanna Healthcare Hldgs Raises FY2026 Sales Guidance from $2.540B-$2.560B to $2.560B-$2.580B vs $2.559B Est
Full Year 2026 GuidanceThe following is our guidance reflecting our increased expectations for revenue and Adjusted EBITDA for the full fiscal year 2026 (year ending January 2, 2027):Revenue of between $2.56 and $2.58
05-14 19:05
Aveanna Healthcare Hldgs Q1 Adj. EPS $0.18 Beats $0.13 Estimate, Sales $647.915M Beat $613.191M Estimate
Aveanna Healthcare Hldgs (NASDAQ:AVAH) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.13 by 38.46 percent. This is a 80 percent increase over earnings of $0.10 per share
05-14 19:03
BRIEF-Aveanna Healthcare Q1 EPS USD 0.19
BRIEF-Aveanna Healthcare Q1 EPS USD 0.19 May 14 (Reuters) - Aveanna Healthcare Q1 net income USD 41.7 million. Q1 revenue USD 647.9 million vs. IBES estimate USD 613.2 million Q1 adjusted EBITDA USD 84.4 million
05-14 19:00
